Literature DB >> 22284245

Erythrocyte mechanical fragility is increased in patients with type 2 diabetes.

Giuseppe Lippi1, Mariella Mercadanti, Rosalia Aloe, Giovanni Targher.   

Abstract

BACKGROUND: Anemia is common among patients with type 2 diabetes. We determined whether type 2 diabetic patients significantly differed in erythrocyte mechanical fragility as compared with nondiabetic subjects.
METHODS: We recruited 25 Caucasian patients with type 2 diabetes (14 men and 11 women; mean age 58±8 years) and 25 age-, race- and sex-matched nondiabetic individuals. The fragility of erythrocytes was tested by inducing mechanical hemolysis by double aspiration of K(2)EDTA blood through a 0.5 mL insulin syringe equipped with a very thin needle. The plasma was then separated from the blood cells by centrifugation at 2000 xg for 15 min at room temperature. A Beckman Coulter DxC 800 was used to measure the hemolysis index by direct spectrophotometry.
RESULTS: Compared with matched nondiabetic controls, type 2 diabetic patients had a significantly increased mechanical fragility of erythrocytes (hemolysis index ratio 21±13 vs. 14±10, p=0.02). Univariable linear regression analysis revealed that there was a strong positive association between percent hemolysis and fasting plasma glucose (r=0.669, p<0.001) and hemoglobin A1c (r=0.549, p<0.005) in type 2 diabetic subjects, but not in matched nondiabetic controls.
CONCLUSIONS: Our data suggest that patients with type 2 diabetes have a significantly higher erythrocyte mechanical fragility than matched nondiabetic subjects, and that fasting plasma glucose is the strongest correlate of increased mechanical fragility of erythrocytes in this patients group.
Copyright © 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22284245     DOI: 10.1016/j.ejim.2011.11.004

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  12 in total

Review 1.  Diabetes mellitus and burns. Part I-basic science and implications for management.

Authors:  Ioannis Goutos; Rebecca Spenser Nicholas; Atisha A Pandya; Sudip J Ghosh
Journal:  Int J Burns Trauma       Date:  2015-03-20

2.  Red Blood Cell Mechanical Fragility Test for Clinical Research Applications.

Authors:  Luke A Ziegler; Salim E Olia; Marina V Kameneva
Journal:  Artif Organs       Date:  2016-12-07       Impact factor: 3.094

3.  Diabetic foot disease is associated with reduced erythrocyte deformability.

Authors:  Avivit Cahn; Leonid Livshits; Ariel Srulevich; Itamar Raz; Shaul Yedgar; Gregory Barshtein
Journal:  Int Wound J       Date:  2015-05-28       Impact factor: 3.315

4.  Age-Related Modulations in Erythrocytes under Blood Bank Conditions.

Authors:  Carl Hsieh; N C Srinivasa Prabhu; Vani Rajashekaraiah
Journal:  Transfus Med Hemother       Date:  2019-07-02       Impact factor: 3.747

Review 5.  Sources and implications of NADH/NAD(+) redox imbalance in diabetes and its complications.

Authors:  Jinzi Wu; Zhen Jin; Hong Zheng; Liang-Jun Yan
Journal:  Diabetes Metab Syndr Obes       Date:  2016-05-10       Impact factor: 3.168

6.  MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines.

Authors:  Bo Burla; Makoto Arita; Masanori Arita; Anne K Bendt; Amaury Cazenave-Gassiot; Edward A Dennis; Kim Ekroos; Xianlin Han; Kazutaka Ikeda; Gerhard Liebisch; Michelle K Lin; Tze Ping Loh; Peter J Meikle; Matej Orešič; Oswald Quehenberger; Andrej Shevchenko; Federico Torta; Michael J O Wakelam; Craig E Wheelock; Markus R Wenk
Journal:  J Lipid Res       Date:  2018-08-16       Impact factor: 5.922

7.  Red cell distribution width and erythrocyte osmotic stability in type 2 diabetes mellitus.

Authors:  Maria Aparecida Knychala; Mario da Silva Garrote-Filho; Breno Batista da Silva; Samantha Neves de Oliveira; Sarah Yasminy Luz; Manuela Ortega Marques Rodrigues; Nilson Penha-Silva
Journal:  J Cell Mol Med       Date:  2021-02-16       Impact factor: 5.310

8.  The Haematological Effects of Oleanolic Acid in Streptozotocin-Induced Diabetic Rats: Effects on Selected Markers.

Authors:  Charity M Baloyi; A Khathi; Ntethelelo H Sibiya; Phikelelani S Ngubane
Journal:  J Diabetes Res       Date:  2019-11-19       Impact factor: 4.011

9.  The Impact of Glycemic Status and Metformin Administration on Red Blood Cell Indices and Oxidative Stress in Type 2 Diabetic Patients.

Authors:  Adel Abdel-Moneim; Eman Salah Abdel-Reheim; Margit Semmler; Wessam Addaleel
Journal:  Malays J Med Sci       Date:  2019-08-29

10.  The chlorite-based drug WF10 constantly reduces hemoglobin A1c values and improves glucose control in diabetes patients with severe foot syndrome.

Authors:  Paiboon Maraprygsavan; Jarasporn Mongkolsuk; Juergen Arnhold; Friedrich-Wilhelm Kuehne
Journal:  J Clin Transl Endocrinol       Date:  2016-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.